Philip M. Sobolesky

Statistics

Publications

Citations

362

H-Index

Active since

2014

Affiliations

University of California San Diego(Current)

Thomas Jefferson University

Medical University of South Carolina

Santa Clara Valley Medical Center

College of Charleston

Philip M. Sobolesky is an author at University of California San Diego specializing in cannabinoid pharmacology, thc blood concentration, and substance use disorders.

ORCID

Publications per year

2014–2023

Publications

Driving Performance and Cannabis Users’ Perception of Safety

Thomas D. Marcotte, Anya Umlauf, David J. Grelotti et al. · JAMA Psychiatry · 2022 · 94 citations · Full text

Medicine, Behavioral Sciences, Substance Use Disorders +14

Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath

Jacqueline A. Hubbard, Breland E. Smith, Philip M. Sobolesky et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2019 · 54 citations · Full text

Pharmacy, Pharmacology, Toxicology +15

Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease

Wei Hou, Michael G. Janech, Philip M. Sobolesky et al. · Bioscience Reports · 2020 · 37 citations · Full text

Medicine, Biochemistry, Pathology +17

Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath

Jacqueline A. Hubbard, Melissa Hoffman, Shannon Ellis et al. · Journal of Analytical Toxicology · 2021 · 37 citations

Nursing, Pharmacology, Substance Abuse Toxicology +12

Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid

Philip M. Sobolesky, Breland E. Smith, Jacqueline A. Hubbard et al. · Clinica Chimica Acta · 2019 · 33 citations · Full text

Natural Sciences, Pharmaceutical Analysis, Pharmacology +13

1–5 of 11